LifeMD (LFMD) Director MacRae Calum Archibald Receives 35,000 Shares

What Happened Calum MacRae (listed in the filing as MACRAE CALUM ARCHIBALD), a director of LifeMD, Inc. (LFMD), was granted 35,000 restricted shares on August 11, 2026. The shares were issued at $0.00 (no cash paid) as an award (transaction code A). The grant is subject to vesting and will vest on June 1, 2027. This was an award/grant—not a purchase or sale.

Key Details

• Transaction date: August 11, 2026
• Filing date: August 13, 2026 (filed timely)
• Transaction type/code: Award/Grant (A)
• Shares granted: 35,000; price per share: $0.00 (no immediate cash value recorded)
• Vesting: June 1, 2027 (per footnote)
• Shares owned after transaction: Not reported in the provided data
• No 10b5‑1 plan, tax‑withholding, or sale noted in the provided information

Context Restricted stock awards are commonly used for director compensation and typically carry vesting and transfer restrictions until the vesting date. They are not an immediate market purchase signal; the economic interest may change as shares vest or if/when the insider sells after vesting. For retail investors, such grants are routine but worth noting as part of insider compensation and long‑term alignment with shareholders.